For research and educational purposes only. Not medical advice.
Adipotide Reference
Educational, not medical advice reference for Adipotide: Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Published work is preclinical in rodent and non-human primate obesity models. There is no published human clinical program for Adipotide.
Regulatory and posture
- Categories
- Fat Loss
- Aliases
- FTPP, Pro-apoptotic peptide, CKGGRAKDC-GG-(KLAKLAK)2
- Evidence posture
- preclinical - Preclinical rodent and primate data only. There is no published human clinical program for Adipotide. Community fat-loss framing is extrapolation from animal models.
- Regulatory status
- No FDA-approved Adipotide drug label. Adipotide / FTPP is a preclinical peptidomimetic that targets prohibitin in adipose-tissue vasculature, studied in rodent and primate obesity models.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed search: adipotide (FTPP) preclinical anti-obesity peptide literature
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.